Table 5.
Controls (N = 15) | Diabetic HD (N = 14) | Nondiabetic HD (N = 14) | |
---|---|---|---|
Heart rate (/min) | 65.37 (57.50–73.25) | 79.89 (71.69–88.10) | 78.79 (71.89–85.70)* |
SDNNa (ms) | 31.11 (22.53–42.96) | 17.03 (12.34–23.49) | 17.75 (13.55–23.25)* |
pNN50 (%) | 6.13 (0–12.57) | 5.36 (0–11.78) | 2.28 (0–7.67) |
VLFa (s2 x10−3) | 0.57 (0.30–1.08) | 0.14 (0.07–0.27)* | 0.20 (0.12–0.34) |
LFa (s2 x10−3) | 0.32 (0.13–0.76) | 0.08 (0.03–0.19) | 0.09 (0.04–0.18) |
HFa (s2 x10−3) | 0.27 (0.14–0.52) | 0.10 (0.05–0.20) | 0.07 (0.04–0.12)* |
LF/HFa | 1.19 (0.65–2.17) | 0.76 (0.41–1.38) | 1.27 (0.77–2.11) |
* = p < 0.05 vs. controls; 95 % CI: 95 % Confidence Interval.
aBecause of skewness of the distribution of the HRV parameters we calculated geometric means (± 95 % CI)